US Patent

US10426787 — Topical compositions and methods for treating psoriasis

Method of Use · Assigned to Bausch Health US LLC · Expires 2036-06-06 · 10y remaining

Vulnerability score 62/100 Moderate — design-around opportunities exist

What this patent protects

This patent protects topical pharmaceutical compositions containing a combination of a corticosteroid and a retinoid for treating psoriasis.

USPTO Abstract

Topical pharmaceutical compositions comprise a combination of a corticosteroid and a retinoid; and methods for treating psoriasis with same. In one embodiment, the corticosteroid comprises halobetasol propionate, and the retinoid comprises tazarotene.

Drugs covered by this patent

FDA Patent Use Codes

When a patent is method-of-use, FDA lists it once per applicable indication ("U-code"). Each U-code carves out a specific therapeutic use that generic filers must either license or design around.

Code	Description	Drug
`U-2625`	—

Patent Metadata

Patent number: US10426787
Jurisdiction: US
Classification: Method of Use
Expires: 2036-06-06
Drug substance claim: No
Drug product claim: No
Assignee: Bausch Health US LLC
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.